ArticleMedical & biological engineering & computing2026
ADBrainNet: a deep neural network for Autism Spectrum Disorder (ASD) and Attention Deficit and Hyperactivity Disorder (ADHD) classification using resting-state fMRI images based on explainable artificial intelligence.
Article in Medical & biological engineering & computing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Autism Spectrum Disorder (ASD) and Attention Deficit and Hyperactivity Disorder (ADHD) are two psychiatric disorders frequently encountered in children. ADHD is further categorized into three subtypes. The diagnostic processes for these conditions are complex and often prone to misclassification. We proposed a lightweight deep neural network, ADBrainNet, to differentiate ASD, ADHD combined, ADHD hyperactive/impulsive, ADHD inattentive and neurotypical individuals. Our methodology was benchmarked against prevalent ImageNet transfer learning methods, including AlexNet, MobileNet, ResNet18, and Xception, for training on resting-state fMRI images sourced from ABIDE and ADHD-200 datasets. ADBrainNet achieved superior performance on the independent external testing set through five-fold cross-validation, with a mean (± standard deviation) accuracy, precision, recall, and F1 score of 61.87% (± 5.59%), 65.72% (± 6.98%), 61.87% (± 5.59%), and 62.50% (± 5.78%), respectively. Furthermore, the explainable artificial intelligence algorithm LIME was employed to explore the most significant features during ADBrainNet's decision process. Our model provides an interpretable computational framework for neuroimaging-based classification between ASD and ADHD subtypes. This approach may inform future research and, upon further validation and comparison with clinician performance, could potentially aid in patient assessment, stratification, and management of psychiatric disorders.
Indexed as
Identifiers
41781648What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.